Perceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study.
Trond Røed PettersenJan SchjøttHeather G AlloreBjørn BendzBritt BorregaardBengt FridlundAlf Inge LarsenJan Erik NordrehaugSvein RotevatnTore Wentzel-LarsenTone Merete NorekvålPublished in: BMJ open (2022)
Mistrust and uncertainty about the safety and efficacy of generic medicines remains in a sizeable proportion of patients after PCI. This applies especially to those of lower socioeconomic status, older age, female sex, immigrants and those with poorer mental health. However, this study demonstrated a shift towards more positive perceptions of generic medicines in the longer term.
Keyphrases
- percutaneous coronary intervention
- mental health
- healthcare
- coronary artery disease
- end stage renal disease
- acute myocardial infarction
- acute coronary syndrome
- st segment elevation myocardial infarction
- primary care
- antiplatelet therapy
- st elevation myocardial infarction
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery bypass grafting
- prognostic factors
- clinical trial
- preterm infants
- atrial fibrillation
- physical activity
- community dwelling
- left ventricular
- mental illness
- preterm birth
- gestational age